BRIEF-Cadila Healthcare says Zydus gets final USFDA approval for drug to treat migraine

Last Updated: Mon, Jun 19, 2017 10:20 hrs

June 19 (Reuters) - Cadila Healthcare Ltd

* Says Zydus receives final approval from USFDA for Eletriptan Hydrobromide tablets

* Says drug will be used in treatment of migraine

* Says drug will be produced at group's formulation facility at Pharma SEZ in Ahmedabad Source text for Eikon: Further company coverage:

More from Sify: